Abstract: The present disclosure relates to an organic electroluminescent compound, a plurality of host materials, and an organic electroluminescent device comprising the same. By comprising the compound according to the present disclosure or by comprising a specific combination of compounds according to the present disclosure as a plurality of host materials, it is possible to produce an organic electroluminescent device having improved driving voltage, luminous efficiency, and/or lifetime properties compared to the conventional organic electroluminescent devices.

Abstract: A semiconductor device fabrication apparatus including a grinder comprising a grinding part, the grinding part configured to grind a first surface of a substrate, a laser emitter configured to emit a femtosecond pulse laser to the first surface of the substrate transferred from the grinder, and a mount configured to attach a die attach film to the first surface of the substrate transferred from the laser emitter, wherein the grinding part is configured to grind the first surface of the substrate, which has been introduced into the grinder, and the laser emitter is configured to emit the femtosecond pulse laser to the ground first surface of the substrate may be provided.

Abstract: In a method and a system for decolorizing and deodorizing a polyhydric alcohol according to embodiments of the present invention, a mixture liquid containing a first polyhydric alcohol obtained by a separation process is prepared. The mixture liquid is subjected to a distillation treatment to preliminarily remove substances with different colors and odors to generate a pre-treatment liquid. The pre-treatment liquid is subjected to an adsorption treatment. Through a combination of the distillation treatment and the adsorption treatment, the removing efficiency of the substances with different colors and odors can be increased.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.

Abstract: A method for treating an inflammatory disease, a skin disease or a skin wrinkle according to an embodiment of the present invention includes administering or applying a composition including 1,2-butandediol to a subject in need thereof. The composition including-butanediol may be used as an anti-inflammatory, anti-oxidative or anti-wrinkle active ingredient. 2,3-butanediol can be used as an active ingredient of a pharmaceutical or cosmetic composition.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.

Abstract: In a method and a system for decolorizing and deodorizing a polyhydric alcohol according to embodiments of the present invention, a mixture liquid containing a first polyhydric alcohol obtained by a separation process is prepared. The mixture liquid is subjected to a distillation treatment to preliminarily remove substances with different colors and odors to generate a pre-treatment liquid. The pre-treatment liquid is subjected to an adsorption treatment. Through a combination of the distillation treatment and the adsorption treatment, the removing efficiency of the substances with different colors and odors can be increased.

Abstract: A method for creating a site on a user terminal connected by a computer network to a site management system includes providing a plurality of cards having predefined functions to the user terminal; and creating a site including at least one of a page corresponding to a card selected at the user terminal by a user from among the plurality of cards and a page including, as a component, at least one card selected at the terminal. The plurality of cards includes a general card configured through a selection and a combination of components by the user and a function card of which a function and a structure are predetermined.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.

Abstract: The present invention relates to an apparatus and a method for fermenting, separating, and refining a product, which is produced by cultivating a microorganism. The apparatus and the method for fermenting, separating, and refining, of the present invention, can separate and refine the product that is produced by microbial fermentation in a simple, continuous manner and with high efficiency.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.

Abstract: A search service providing apparatus including a memory configured to store computer-readable instructions, and one or more processors configured to execute the instructions to receive a search request including input data from a user terminal, the input data including a keyword, generate a search result in response to the input data, the search result including a keyword-related advertisement and a route code corresponding to the keyword-related advertisement, transmit the search result to the user terminal, monitor a user event with regard to the route code, and determine fees to be charged on the keyword-related advertisement, based on the user event may be provided.

Abstract: A method for creating a site on a user terminal connected by a computer network to a site management system includes providing a plurality of cards having predefined functions to the user terminal; and creating a site including at least one of a page corresponding to a card selected at the user terminal by a user from among the plurality of cards and a page including, as a component, at least one card selected at the terminal. The plurality of cards includes a general card configured through a selection and a combination of components by the user and a function card of which a function and a structure are predetermined.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.

Abstract: The present invention relates to an apparatus and a method for fermenting, separating, and refining a product, which is produced by cultivating a microorganism. The apparatus and the method for fermenting, separating, and refining, of the present invention, can separate and refine the product that is produced by microbial fermentation in a simple, continuous manner and with high efficiency.

Abstract: The present invention relates to an apparatus and a method for fermenting, separating, and refining a product, which is produced by cultivating a microorganism. The apparatus and the method for fermenting, separating, and refining, of the present invention, can separate and refine the product that is produced by microbial fermentation in a simple, continuous manner and with high efficiency.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.

Abstract: This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g., a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.